Elixinol Global Limited (Elixinol Global or the Company) (ASX:EXL; OTC:ELLXF) is pleased to announce the successful completion of the institutional component of its accelerated non-renounceable pro rata entitlement offer (Entitlement Offer), details of which were announced to ASX on Tuesday, 5 May 2020 as well as provide an update on the Entitlement Offer.
For more information, download the attached PDF:
Download this document